These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4199277)

  • 1. Observations of the mechanism of action of the sulfonylureas under clinical conditions.
    Jackson WP; Van Mieghem W; Keller P
    Metabolism; 1973 Sep; 22(9):1155-62. PubMed ID: 4199277
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sulfonylureas on lipid levels in diabetic patients].
    Sgambato S; Cristiano L; Torella R
    Rass Int Clin Ter; 1968 Apr; 48(8):455-62. PubMed ID: 5736035
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect.
    Hecht A; Gershberg H; Hulse M
    Metabolism; 1973 May; 22(5):723-33. PubMed ID: 4704717
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of diuresis in the rat by chlorpropamide, glibenclamide and tolbutamide.
    Foy JM; Lucas PD
    Experientia; 1975 May; 31(5):570-3. PubMed ID: 237771
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes mellitus: the thin maturity-onset diabetic.
    Br Med J; 1972 Sep; 3(5828):692-4. PubMed ID: 4631184
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synergism between oral diabetics and insulin].
    Consiglio D; Mantia G; Hopps V
    Boll Soc Ital Biol Sper; 1971 Nov; 47(22):737-42. PubMed ID: 5004485
    [No Abstract]   [Full Text] [Related]  

  • 11. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.
    Chu PC; Conway MJ; Krouse HA; Goodner CJ
    Ann Intern Med; 1968 Apr; 68(4):757-69. PubMed ID: 4868334
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effects of acute intravenous loads of tolbutamide, acetohexamide and chlorpropamide in normal and diabetic subjects.
    Wajchenberg BL; Pereira VG; Pupo AA
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):143-7. PubMed ID: 5322748
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].
    Aiello C; Turner D; Aparicio NJ; De Turner EA; Vazquez A
    Acta Diabetol Lat; 1973; 10(1):30-53. PubMed ID: 4197367
    [No Abstract]   [Full Text] [Related]  

  • 14. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacology of sulfonylureas.
    Skillman TG; Feldman JM
    Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glibenclamide--a better antidiabetic agent?].
    Blohmé G
    Lakartidningen; 1972 Dec; 69(52):6147-9. PubMed ID: 4631025
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.
    Heine P; Kewitz H; Schnapperelle U
    Eur J Clin Pharmacol; 1974 Aug; 7(5):321-30. PubMed ID: 4213593
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hypoglycemic sulfonylureas on hepatic fructose metabolism in the rat.
    Schönborn J; Poser W; Panten U; Hasselblatt A
    Horm Metab Res; 1974 Jul; 6(4):284-3. PubMed ID: 4213055
    [No Abstract]   [Full Text] [Related]  

  • 19. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of glibenclamide on non-esterified fatty acid levels in the plasma of the severely alloxan diabetic rat.
    Foy JM; Standing VF
    Experientia; 1973 Aug; 29(8):1006-8. PubMed ID: 4200262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.